Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency-Reference-Cited by-同舟云学术

Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency

Published:2004-01 Issue:1 Volume:110 Page:22-29
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Quartier Pierre,Bustamante Jacinta,Sanal Ozden,Plebani Alessandro,Debré Marianne,Deville Anne,Litzman Jiri,Levy Jacov,Fermand Jean-Paul,Lane Peter,Horneff Gerd,Aksu Guzide,Yalçin Isik,Davies Graham,Tezcan Ilhan,Ersoy Furgen,Catalan Nadia,Imai Kohsuhe,Fischer Alain,Durandy Anne

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Immunodeficiency with hyper-IgM (HIM);Notarangelo;Immunodefic. Rev.,1992

2. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome;Allen;Science,1993

3. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome;Aruffo;Cell,1993

4. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM;DiSanto;Nature,1993

5. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome;Notarangelo;Immunol. Today,1996

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunologists’ Perspectives on Monogenic Inflammatory Bowel Diseases;Turkish Journal of Immunology;2024-04-18

2. A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families;Immunogenetics;2024-04-08

3. Regulation of BCR-mediated Ca ²⁺ mobilization by MIZ1-TMBIM4 safeguards IgG1 ⁺ GC B cell–positive selection;Science Immunology;2024-04-05

4. Immunodeficiency Syndromes Seen During the Neonatal Period;Principles of Neonatology;2024

5. Regulation of BCR-mediated Ca²⁺mobilization by MIZ1-TIMBIM4 safeguards IgG1⁺GC B cell positive selection;2023-07-19